Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following business segments: Proprietary Products, and Distribution. The Proprietary Products segment develops, manufactures and sells plasma-derived protein therapeutics products. The Distribution segment supplies plasma based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Ness Ziona, Israel.